ClinicalTrials.Veeva

Menu
U

Universitatsklinikum Leipzig AoR | Medizinische Klinik III - Rheumatologie

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JNJ-77242113
Povorcitinib
Methoxsalen
LGX818
GC4419
Selonsertib
MBX-8025
Obeticholic Acid
Pemigatinib
Guselkumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 14 total trials

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

The purpose of the study is to see how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo and deu...

Active, not recruiting
Plaque Psoriasis
Drug: Deucravacitinib Matching Placebo
Drug: JNJ-77242113 Matching Placebo

The purpose of this study is to demonstrate that Super-Responders (SRe; defined as psoriasis participants who receive on-label guselkumab treatment u...

Active, not recruiting
Psoriasis
Drug: Guselkumab
Drug: Placebo Injection

The purpose of this study is to evaluate the efficacy and safety of pemigatinib versus gemcitabine plus cisplatin chemotherapy in first-line treatmen...

Active, not recruiting
Metastatic Cholangiocarcinoma
Unresectable Cholangiocarcinoma
Drug: Gemcitabine
Drug: Cisplatin

This study is being conducted to evaluate the efficacy and safety of povorcitinib in adults with CSU that is inadequately controlled using SOC treatm...

Enrolling
Angioedema
Hives
Drug: Placebo
Drug: Povorcitinib

Trial sponsors

Cook Group logo
Incyte logo
Janssen (J&J Innovative Medicine) logo
CymaBay Therapeutics logo
G
Gilead Sciences logo
I
Janssen (J&J Innovative Medicine) logo
M
Medtronic logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems